Recent

% | $
Quotes you view appear here for quick access.

TiVo Inc. Message Board

  • frankf4u489 frankf4u489 Jun 7, 2013 9:59 AM Flag

    Forget TIVO, CCUR Increases Dividend 100%!

    TIVO is still extremely overvalued here. An extremely undervalued stock in this industry that is beginning to breakout big this morning: Concurrent (CCUR). The company announced yesterday after the close that they are doubling their quarterly cash dividend from $0.06 to $0.12! Their next quarterly cash dividend will be paid to shareholders later this month! CCUR's annual dividend will now be $0.48 and CCUR closed yesterday at only $7.08 per share! CCUR's new dividend yield is an INCREDIBLE 6.8%, one of the highest on the NASDAQ - especially for a small-cap tech stock with rapidly improving fundamentals!

    CCUR's Mediahawk VX on demand video server product just surpassed Cisco (CSCO)'s CDE 250 to become the #1 highest rated VOD solution in the pay-TV industry! CCUR's operating profit in recent quarters has increased from $187,000 to $413,000 to $876,000 and to $1,233,000 for unbelievable growth of 559%!

    CCUR's profits have the potential to skyrocket substantially more this quarter and next quarter with CCUR in March signing a MAJOR contract with Virgin Media, the second largest pay-TV service provider in the UK! CCUR's MediaHawk VX unified CDN solution will be used to support Virgin TV Anywhere, a new cloud-based entertainment service that gives Virgin's 3.8 million pay-TV subscribers the flexibility to enjoy their favorite TV content on computers, laptops, smartphones, and tablets!

    CCUR earned non-GAAP EPS last quarter of $0.16 (excluding share-based compensation and non-cash amortization)! This puts CCUR on track to earn $0.64 per share this calendar year! A conservative P/E of 20 to 30 with full year EPS of $0.64 would make CCUR a $12.80 to $19.20 per share stock! Be sure to start researching CCUR as soon as possible, the Cable Show is Monday through Wednesday of next week!

 
TIVO
9.96-0.11(-1.09%)Jul 31 4:00 PMEDT